Upadacitinib protects against cisplatin-induced renal and hepatic dysfunction without impairing its anticancer activity

Autor: Anbar, Hanan S., Shehab, Naglaa G., El-Rouby, Nadia M.M., Ansari, Marium A., Chenoth, Haseena, Majeed, Maham, Naeem, Komal, Hersi, Fatima, Omar, Hany A.
Zdroj: In European Journal of Pharmaceutical Sciences 1 May 2022 172
Databáze: ScienceDirect